RIDASCREEN® IFX Monitoring – ELISA for the therapeutic drug monitoring (TDM) of Infliximab (Remicade®, RemsimaTM, Inflectra®) in human serum and plasma.
- Validated in clinical trials.
- Highly specific monoclonal antibody MA-IFX6B7.
- Equally well suited for therapeutic drug monitoring of Remicade®, Inflectra®, and RemsimaTM.
- 2 controls at the decision sites (3 and 7 µg/ml IFX).
- Breakable microwell plate.
- Validated for automated 4-Plate-ELISA-Reader.